ArticlePharmacoEconomics2021
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve.
Pedram SendiPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papertrialcites it
ArticlePharmacoEconomics2021
Pedram SendiPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.